Lectenz Bio

Lectenz Bio is a private biotechnology company specializing in glycoscience tools and services, operating from Athens, Georgia, and San Diego, California. The company has developed a proprietary platform called Lectenz®, which are recombinant, lectin-like binding proteins engineered for high specificity and consistency in glycan detection and analysis. Its business model combines product sales (kits, reagents, standards) with fee-for-service analytical work, targeting the research and industrial diagnostics markets. Lectenz Bio positions itself as a solution provider that reduces the complexity and cost barrier for integrating critical glycomics data into broader research and development workflows.

Lectenz®: recombinant, lectin-like binding proteins derived from inactivated glycolytic enzymes and optimized via directed evolution for high-specificity glycan detection and analysis.

Lectenz Bio competes with traditional suppliers of natural lectins (e.g., Vector Laboratories) and providers of complex, mass spectrometry-based glycomics services. Its differentiation lies in offering engineered reagents that promise superior consistency and specificity in a more accessible format, targeting researchers who find current options either too unreliable or too technically demanding.